Contribution of a typing method based on IS256 probing of SmaI-digested cellular DNA to discrimination of European phage type 77 methicillin-resistant Staphylococcus aureus strains.

Journal of Clinical Microbiology
Anne MorvanNévine El Solh

Abstract

The incidence of infections with phage type 77 methicillin-resistant Staphylococcus aureus (MRSA) strains increased in France in 1987. These strains are widespread in numerous European hospitals. The SmaI restriction profiles of total DNA extracted from 74 phage type 77 MRSA strains isolated from 1987 to 1994 in 10 hospitals in eight European cities (in France, Belgium, and Spain) were analyzed. Hybridization with a probe containing a 468-bp DNA fragment from within the transposase gene of the insertion sequence IS256 was also examined. Forty-three SmaI profiles were detected. Twenty major genotypes were identified, and each genotype contained strains with the same profile or profiles which differed by no more than three bands. Strains isolated in different countries and at several-year intervals were often grouped within the same genotype. A larger number of genotypes could be discriminated by analysis of the patterns of hybridization with the IS256 probe. SmaI restriction fragments with the same apparent electrophoretic mobility could, in some cases, be distinguished by the presence or the absence of nucleotide sequences hybridizing with IS256. The strains that grouped within the same genotype after hybridization with IS256 w...Continue Reading

References

Nov 1, 1992·Plasmid·K G DykeN el Solh
Dec 1, 1992·Epidemiology and Infection·W Witte, H Grimm
Apr 1, 1992·Epidemiology and Infection·P AparicioB D Cookson
May 1, 1992·Journal of Medical Microbiology·S Walcher-SalesseN el Solh
Jan 1, 1991·The Journal of Hospital Infection·A G AboukasmJ F Acar
Aug 1, 1991·Journal of Medical Microbiology·C Monzon-MorenoN E Solh
Sep 1, 1995·Journal of Clinical Microbiology·L A TeixeiraA Tomasz
Aug 1, 1995·Journal of Clinical Microbiology·I CoutoH de Lencastre
Feb 1, 1994·Journal of Clinical Microbiology·F C TenoverR Hollis
Jan 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H de LencastreA Tomasz
Jun 1, 1993·Epidemiology and Infection·A VindelJ A Sáez Nieto
Jun 1, 1996·Journal of Clinical Microbiology·M S SmeltzerL A Young
Jan 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Y LiuC Y Tseng
Jan 1, 1995·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·I S SanchesH de Lencastre
Jan 1, 1995·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·B N KreiswirthM H Levi

❮ Previous
Next ❯

Citations

Jun 29, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·T A WichelhausV Brade
Apr 1, 1999·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L E NicolleJ Embil
Jan 6, 2001·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·A van Belkum
Nov 9, 2004·Folia Microbiologica·J StepánJ Doskar
May 8, 2004·Journal of Clinical Microbiology·Salim TradNévine El-Solh

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.